Article
Artemisinin combination therapy fails even in the absence of Plasmodium falciparum kelch13 gene polymorphism in Central India.
Scientific reports - 11 May 2021
Das Sabyasachi, Kar Amrita, Manna Subhankar, Mandal Samaresh, Mandal Sayantani, Das Subhasis, Saha Bhaskar, Hati Amiya Kumar
Abstract excerpt
Artemisinin is the frontline fast-acting anti-malarial against P. falciparum. Emergence and spread of resistant parasite in eastern-India poses a threat to national malaria control programs. Therefore, the objective of our study is to evaluate the artesunate-sulfadoxine-pyrimethamine efficacy in Central India. 180 monoclonal P. falciparum-infected patients received standard ASSP therapy during August 2015-January...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
